Echocardiography and Noninvasive Vascular Testing Evaluation: March 24, 2025

Please select one: *

I am in active clinical practice

I am retired

I am a student

Other

Please score your agreement with or assessment of the following questions and statements by rating on a scale of 1 to 5, with 5 representing the highest level of satisfaction or agreement. *

Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable

	5	4	3	2	1	NA
The skills learned in this CME course enhanced my professional competence.	The skills learned in this CME course enhanced my professional competence. - 5	The skills learned in this CME course enhanced my professional competence. - 4	The skills learned in this CME course enhanced my professional competence. - 3	The skills learned in this CME course enhanced my professional competence. - 2	The skills learned in this CME course enhanced my professional competence. - 1	The skills learned in this CME course enhanced my professional competence. - NA
The skills learned in this CME course will be applied in the treatment of my patients	The skills learned in this CME course will be applied in the treatment of my patients - 5	The skills learned in this CME course will be applied in the treatment of my patients - 4	The skills learned in this CME course will be applied in the treatment of my patients - 3	The skills learned in this CME course will be applied in the treatment of my patients - 2	The skills learned in this CME course will be applied in the treatment of my patients - 1	The skills learned in this CME course will be applied in the treatment of my patients - NA

How confident are you in your ability to: *

5 = High level of confidence 4 = Moderately high level of confidence 3 = Average level of confidence 2 = Low level of confidence 1 = No level of confidence

	5	4	3	2	1
Integrate the 2024 AHA/ACC Guideline for the Management of Hypertrophic Cardiomyopathy into clinical practice.	Integrate the 2024 AHA/ACC Guideline for the Management of Hypertrophic Cardiomyopathy into clinical practice. - 5	Integrate the 2024 AHA/ACC Guideline for the Management of Hypertrophic Cardiomyopathy into clinical practice. - 4	Integrate the 2024 AHA/ACC Guideline for the Management of Hypertrophic Cardiomyopathy into clinical practice. - 3	Integrate the 2024 AHA/ACC Guideline for the Management of Hypertrophic Cardiomyopathy into clinical practice. - 2	Integrate the 2024 AHA/ACC Guideline for the Management of Hypertrophic Cardiomyopathy into clinical practice. - 1
Apply guideline-directed strategies, including assessing a patient’s risk for sudden cardiac death, as a critical component of disease management.	Apply guideline-directed strategies, including assessing a patient’s risk for sudden cardiac death, as a critical component of disease management. - 5	Apply guideline-directed strategies, including assessing a patient’s risk for sudden cardiac death, as a critical component of disease management. - 4	Apply guideline-directed strategies, including assessing a patient’s risk for sudden cardiac death, as a critical component of disease management. - 3	Apply guideline-directed strategies, including assessing a patient’s risk for sudden cardiac death, as a critical component of disease management. - 2	Apply guideline-directed strategies, including assessing a patient’s risk for sudden cardiac death, as a critical component of disease management. - 1

How satisfied or dissatisfied were you with the Speaker's effectiveness in addressing the learning objectives? *

Scoring Key: 5=Strongly satisfied 4= Somewhat satisfied 3=Neither satisfied nor dissatisfied 2= Somewhat dissatisfied 1=Strongly dissatisfied

	5	4	3	2	1
Explain the importance of shared decision-making in optimizing clinical care for patients with hypertrophic cardiomyopathy (HCM).	Explain the importance of shared decision-making in optimizing clinical care for patients with hypertrophic cardiomyopathy (HCM). - 5	Explain the importance of shared decision-making in optimizing clinical care for patients with hypertrophic cardiomyopathy (HCM). - 4	Explain the importance of shared decision-making in optimizing clinical care for patients with hypertrophic cardiomyopathy (HCM). - 3	Explain the importance of shared decision-making in optimizing clinical care for patients with hypertrophic cardiomyopathy (HCM). - 2	Explain the importance of shared decision-making in optimizing clinical care for patients with hypertrophic cardiomyopathy (HCM). - 1
Implement appropriate evaluation, treatment and longitudinal care strategies, including referral to multidisciplinary HCM centers with specialized expertise.	Implement appropriate evaluation, treatment and longitudinal care strategies, including referral to multidisciplinary HCM centers with specialized expertise. - 5	Implement appropriate evaluation, treatment and longitudinal care strategies, including referral to multidisciplinary HCM centers with specialized expertise. - 4	Implement appropriate evaluation, treatment and longitudinal care strategies, including referral to multidisciplinary HCM centers with specialized expertise. - 3	Implement appropriate evaluation, treatment and longitudinal care strategies, including referral to multidisciplinary HCM centers with specialized expertise. - 2	Implement appropriate evaluation, treatment and longitudinal care strategies, including referral to multidisciplinary HCM centers with specialized expertise. - 1
Incorporate family history assessment, genetic counseling and discussion of genetic testing options into the management of patients with HCM.	Incorporate family history assessment, genetic counseling and discussion of genetic testing options into the management of patients with HCM. - 5	Incorporate family history assessment, genetic counseling and discussion of genetic testing options into the management of patients with HCM. - 4	Incorporate family history assessment, genetic counseling and discussion of genetic testing options into the management of patients with HCM. - 3	Incorporate family history assessment, genetic counseling and discussion of genetic testing options into the management of patients with HCM. - 2	Incorporate family history assessment, genetic counseling and discussion of genetic testing options into the management of patients with HCM. - 1
Evaluate a patient’s risk for sudden cardiac death as a critical component of disease management.	Evaluate a patient’s risk for sudden cardiac death as a critical component of disease management. - 5	Evaluate a patient’s risk for sudden cardiac death as a critical component of disease management. - 4	Evaluate a patient’s risk for sudden cardiac death as a critical component of disease management. - 3	Evaluate a patient’s risk for sudden cardiac death as a critical component of disease management. - 2	Evaluate a patient’s risk for sudden cardiac death as a critical component of disease management. - 1

Was this course fair, balanced and without commercial bias? *

Yes

No

If you checked "No,” please explain why: *

What, if any, new skills/strategies will you apply in your clinical practice? *

If you do not plan to implement any new skills/strategies in your clinical practice, what is keeping you from doing so? *

Please provide any additional comments or suggestions.

Name and ABS ID Required to claim MOC

You are here

Echocardiography and Noninvasive Vascular Testing Evaluation: March 24, 2025